{"prompt": "['5.0', 'Grouping Factor:', 'Study Stage:', '1 1=Safety Run-in VS 2=Expansion portion', '6.0', 'Registration Procedures', '6.1', 'Safety Run-In', 'Prior to discussing protocol entry with the patient, call the MCCC Registration Office', 'to insure that a place on the protocol is open to the patient.', 'To register a patient, fax', ')', 'a completed eligibility checklist to the Mayo Clinic', 'Cancer Center (MCCC) Registration Office between 8 a.m. and 4:30 p.m. central time Monday', 'through Friday.', '6.2', 'Registration, following the completion of run-in portion:', '6.21', 'Registering a patient', 'To register a patient, access the Mayo Clinic Cancer Center (MCCC) web page and enter', 'the registration/randomization application. Theregistration/ randomization application is', 'available 24 hours a day, 7 days a week. Back up and/or system support contact', 'information is available on the website. If unable to access the website, call the MCCC', 'Registration Office at', 'between the hours of 8 a.m. and 4:30 p.m. Central', 'Time (Monday through Friday).', 'The instructions for the registration/randomizatio application are available on the', 'MCCC web page', ')', 'and detail the process for', 'completing and confirming patient registration. Prior to initiation of protocol treatment,', 'this process must be completed in its entirety and an MCCC subject ID number must be', 'available as noted in the instructions. It is the responsibility of the individual registering', 'the patient to confirm the process has been successfully completed prior to release of the', 'study agent. Patient registration via the registration/randomizatior application can be', 'confirmed in any of the following ways:', 'Contact the MCCC Registration Office', 'If the patient was fully', 'registered, the MCCC Registration Office staff can access the information from', 'the centralized database and confirm the registration.', 'Refer to \"Instructions for Remote Registration\" in section \"Finding/Displaying', 'Information about A Registered Subject.\"', '6.3', 'Verification of materials', 'Prior to accepting the registration, registration/randomization application will verify the', 'following:', 'IRB approval at the registering institution', 'Patient eligibility', 'Existence of a signed consent form', 'Existence of a signed authorization for use and disclosure of protected health information', '6.4', 'Documentation of IRB approval', 'Documentation of IRB approval must be on file in the Registration Office before an investigator', 'may register any patients.', 'In addition to submitting initial IRB approval documents, ongoing IRB approval documentation', 'must be on file (no less than annually) at the Registration Office (fax:', '). If the', 'necessary documentation is not submitted in advance of attempting patient registration, the', 'registration will not be accepted and the patient may not be enrolled in the protocol until the', 'situation is resolved.']['MC1752', '20', 'When the study has been permanently closed to patient enrollment, submission of annual IRB', 'approvals to the Registration Office is no longer necessary.', '6.5', 'Correlative Research', '6.42', 'Optional', 'An optional correlative research component is part of this study, there will be an option to', 'select if the patient is to be registered onto this component (see Section 17.0).', 'Patient has/has not given permission to give his/her tissue sample for research testing.', '6.6', 'Treatment on protocol', 'Treatment on this protocol must commence at Mayo Clinic under the supervision of a medical', 'oncologist or radiation oncologist', '6.7', 'Treatment start', 'Treatment cannot begin prior to registration and must begin <7 days after registration.', '6.8', 'Pretreatment', 'Pretreatment tests/procedures (see Section 4.0) must be completed within the guidelines specified', 'on the test schedule.', '6.9a', 'Baseline symptoms', 'All required baseline symptoms (see Section 10.6) must be documented and graded.', '6.9b', 'A radiation oncologist has seen the patient and confirms the patient is a suitable candidate', 'for this study.', '6.9c', 'Study drug', 'Study drug is available on site.', '6.9d', 'Patient questionnaire booklets', 'Patient questionnaire booklets are available on site. Copies are not acceptable for these', 'submissions. Booklets should be ordered using the Patient Questionnaire Order Form', 'Protocol Version Date: 21JUN2018']\n\n###\n\n", "completion": "END"}